Non-coding RNAs have long been treated as the genome’s quiet background: transcripts that regulate genes but never produce proteins. A review published in Cell Communication and Signaling argues that this tidy division is breaking down. Advances in translatomics and proteomics have revealed that a subset of non-coding RNAs harbor small open reading frames capable of generating biologically active peptides, and recent studies indicate that these peptides participate in diverse cardiovascular processes, including calcium handling, mitochondrial metabolism, tissue repair, fibrosis, inflammation, and vascular remodeling.

The review, led by Kaiyue Zhang, Xiangyang Peng, Junjie Wu, Houjuan Zuo, and Hesong Zeng, was published as an open-access article on 19 October 2026. Its central claim is not simply that a new class of peptides exists. Rather, the authors argue that the significance of these discoveries extends beyond peptide identification itself, because increasing studies demonstrate that RNA transcripts and encoded peptides can coexist within the same genetic locus and contribute to biological regulation through independent, parallel, cooperative, or antagonistic mechanisms.

This dual-output architecture challenges the traditional binary distinction between coding and non-coding transcripts. In the classical view, a transcript either carries an open reading frame long enough to build a protein or it does not, and its function is defined accordingly. The accumulating evidence suggests a more nuanced picture: some transcripts that were cataloged as non-coding are in fact peptide-producing, and their regulatory roles are not replaced by translation but layered on top of it.

From this pattern, the authors propose a conceptual framework for understanding bifunctional RNAs. Under this framework, a single genetic locus can act as a bifunctional regulatory unit, with the RNA molecule and its encoded peptide operating as two outputs of the same gene. The two outputs may work independently, in parallel, in cooperation, or in opposition, depending on the biological context. The review summarizes current evidence supporting peptide translation from non-coding RNAs and discusses the emerging roles of ncRNA-derived peptides in cardiovascular physiology and disease.

The cardiovascular relevance is broad. Calcium handling governs the electrical and mechanical behavior of heart muscle cells, mitochondrial metabolism determines cellular energy supply, and fibrosis and inflammation drive the remodeling processes that underlie heart failure and vascular disease. Peptides derived from transcripts previously labeled as non-coding have now been implicated across these processes, which means that loci once studied only for their RNA-mediated regulatory functions may also contribute through their peptide products.

Technically, this reclassification depends on translatomics, the systematic study of which transcripts are actively translated, combined with proteomics, which detects the resulting peptide products directly. Small open reading frames are easy to overlook because conventional gene annotation pipelines were built to flag long reading frames typical of protein-coding genes. Ribosome profiling and sensitive proteomic methods have made it possible to detect translation events at loci that annotation had dismissed, revealing a layer of gene expression that earlier surveys missed.

The dual-output model also reframes how genetic variation in cardiovascular disease should be interpreted. If a locus can exert effects through both its RNA transcript and its peptide, then a mutation could disrupt either arm or the balance between them. The review explores how peptide translation expands the functional output of a genetic locus, enabling RNA transcripts and encoded peptides to participate in biological regulation through independent, parallel, cooperative, or antagonistic mechanisms.

The authors extend the framework toward application. They discuss how this dual-output mode of regulation may open new avenues for therapeutic intervention, biomarker development, and bioengineering applications in cardiovascular disease. Because the RNA and peptide arms of a bifunctional locus can be regulated separately, each arm offers a distinct point of control for future drug design and diagnostic marker discovery, although the review presents these as directions rather than demonstrated clinical results.

As a review, the article synthesizes and interprets existing studies rather than reporting new experimental data, and its framework is a proposal intended to organize the field. Even so, the message is pointed: the boundary between coding and non-coding RNA is porous, and a meaningful share of cardiovascular regulation may be carried out by genetic units that produce both a transcript and a peptide, each with its own role in health and disease.

Subject of Research: Peptide translation from non-coding RNAs and bifunctional RNA regulation in cardiovascular disease

Article Title: Beyond non-coding: peptide translation and bifunctional RNA biology in cardiovascular disease

Article References: Zhang, K., Peng, X., Wu, J., Zuo, H., & Zeng, H. (2026). Beyond non-coding: peptide translation and bifunctional RNA biology in cardiovascular disease. Cell Communication and Signaling. https://doi.org/10.1186/s12964-026-03289-x

Image Credits: AI Generated

DOI: 10.1186/s12964-026-03289-x

Keywords: non-coding RNA, peptide translation, bifunctional RNA, cardiovascular disease, translatomics, proteomics, fibrosis, calcium handling, mitochondrial metabolism, vascular remodeling, biomarkers, therapeutics